The British Journal of Psychiatry
Prescription of antipsychotics in people with dementia
Clive Ballard, Anne Corbett, Robert Howard
  • Declaration of interest

    C.B. has received speaker fees and consultancy honoraria from Acadia, Lundbeck, Bristol-Myers Squibb, Napp, Takeda, Onsaka, Synexus and Novartis. A.C. has received honoraria from Bial, Lundbeck, Novartis and Acadia.

Abstract

Gerhard et al clarify our understanding of mortality associated with antipsychotic use in people with dementia, by demonstrating a clear dose relationship and highlighting key questions regarding the relative mortality risk of different atypical antipsychotics. The study also suggests that antipsychotics may confer risks of increased mortality in older people without dementia.

View Full Text

Log in through your institution

Purchase Short-Term Access 
Pay per Article - You may access this article (and download the PDF version) for 1 day for US$30.00.
Pay per Issue - You may access this issue (from the computer you are currently using) for 365 days for US$90.00.
Pay for Admission - You may access all content in The British Journal of Psychiatry (and download the PDF version) for 1 day for US$45.00.
Regain Access - You can regain access to a recent Pay per Article, Pay per Issue, or Pay for Admission purchase if your access period has not yet expired.